Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
Conditions
- Covid19
- Corona Virus Infection
Interventions
- DIAGNOSTIC_TEST: Biochemistry blood test
- DIAGNOSTIC_TEST: Hematology blood test
- DIAGNOSTIC_TEST: D-Dimer test (coagulation)
- DIAGNOSTIC_TEST: Inflammatory markers
- DIAGNOSTIC_TEST: Vital signs
- DIAGNOSTIC_TEST: VAS scale
- DIAGNOSTIC_TEST: WHO Ordinal Score
- DIAGNOSTIC_TEST: COVID-19-Related Symptoms assessment
- DIAGNOSTIC_TEST: COVID-19-Impact on Quality-of-Life Questionnaire
- DIAGNOSTIC_TEST: POST- COVID-19 Functional Status Scale:
- DIAGNOSTIC_TEST: Pregnancy test
- DIAGNOSTIC_TEST: Physical examination
- DIAGNOSTIC_TEST: PK parameters
- DIAGNOSTIC_TEST: SARS-CoV-2 test (PCR)
- DIAGNOSTIC_TEST: ECG
- DRUG: Treatment administration (twice a day)
Sponsor
MGC Pharmaceuticals d.o.o